Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$55.7 - $145.79 $518,845 - $1.36 Million
-9,315 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$135.05 - $182.59 $765,598 - $1.04 Million
-5,669 Reduced 37.83%
9,315 $1.39 Million
Q3 2021

Oct 08, 2021

BUY
$145.58 - $192.14 $409,516 - $540,489
2,813 Added 23.11%
14,984 $2.18 Million
Q2 2021

Jul 09, 2021

BUY
$134.22 - $202.37 $563,724 - $849,954
4,200 Added 52.69%
12,171 $2.38 Million
Q1 2021

Apr 12, 2021

BUY
$140.25 - $196.86 $112,200 - $157,488
800 Added 11.16%
7,971 $1.44 Million
Q4 2020

Jan 26, 2021

SELL
$126.47 - $163.7 $10,749 - $13,914
-85 Reduced 1.17%
7,171 $1.01 Million
Q3 2020

Oct 30, 2020

BUY
$87.44 - $125.0 $78,258 - $111,875
895 Added 14.07%
7,256 $904,000
Q2 2020

Jul 07, 2020

BUY
$58.39 - $89.31 $371,418 - $568,100
6,361 New
6,361 $568,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.39B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Paragon Advisors, LLC Portfolio

Follow Paragon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Advisors, LLC with notifications on news.